known case of cad done angioplasty 2 years back complaining of mild chest pain after exertion ecg showed septal infarction probably old with Trop I negative
Reading File
Finding Sources
Finding Sources
Searching PubMed
"stable angina" AND "prior PCI" AND management
Finding Sources
Finding Sources
Searching PubMed
"chronic coronary syndrome" AND management
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have sufficient information to provide a comprehensive clinical response. Let me synthesize this.
Clinical Assessment & Management
Diagnosis: Stable Exertional Angina (Chronic Coronary Syndrome) in a Known CAD Patient — Post-PCI
Clinical Interpretation
| Finding | Interpretation |
|---|---|
| Known CAD + prior PCI (2 years ago) | High baseline atherosclerotic burden; possible in-stent restenosis or disease progression |
| Mild chest pain on exertion | Classic effort angina — supply-demand mismatch |
| ECG: Septal infarction — probably old | Q waves in V1–V3; consistent with prior LAD territory MI; "probably old" means no acute ST changes |
| Troponin I negative | Rules out acute myocardial injury/NSTEMI |
This presentation is not an acute coronary syndrome. The negative troponin and absence of ECG changes from a new baseline confirm stable ischemic heart disease (SIHD) with recurrent exertional symptoms.
Key concern: New/recurrent exertional angina 2 years after PCI raises the possibility of:
- In-stent restenosis (typically peaks 6–12 months post-PCI, but can occur later)
- Native vessel disease progression
- Inadequate anti-anginal therapy
Immediate Management
1. Symptom Relief
- Sublingual glyceryl trinitrate (GTN) / nitroglycerin spray for acute episodes
2. Optimize Medical Therapy (per ACC/AHA guidelines)
| Drug Class | Recommendation |
|---|---|
| Aspirin 75–100 mg/day | Mandatory unless contraindicated |
| β-blocker | First-line anti-anginal + cardioprotective; reduces heart rate, contractility, O₂ demand |
| High-intensity statin | LDL target < 55 mg/dL; use high-potency statin ± ezetimibe ± PCSK9 inhibitor |
| ACE inhibitor | Especially if diabetes, LV dysfunction, or other vascular disease present |
| Long-acting nitrate or CCB | Add if symptoms persist on β-blocker |
| Rivaroxaban 2.5 mg BD + aspirin | Favorable evidence in stable CAD (COMPASS trial) — consider |
"Aspirin, β-blockers as initial therapy, LDL-lowering with target <55 mg/dL, ACE inhibitor if diabetes or LV dysfunction, sublingual nitroglycerin for immediate relief." — Goldman-Cecil Medicine, Table 56-7
Risk Stratification — Next Steps
Non-invasive stress testing is the priority to quantify ischemic burden:
| Test | Indication |
|---|---|
| TMT (Exercise ECG) | If ECG interpretable; note baseline Q waves may limit interpretation |
| Stress Echo / Nuclear (SPECT) | Preferred given baseline ECG changes (old septal infarction) — better localization of ischemia |
| CCTA | Good for ruling out significant stenosis if prior stenting allows |
| Invasive coronary angiography | If high-risk features on noninvasive testing, CCS class III/IV, or suspected in-stent restenosis |
High-risk features warranting urgent angiography include:
- LVEF < 35%
- High-risk treadmill score (≤ −11)
- Large perfusion defect on stress imaging
- Stress-induced wall motion abnormality at low dose/heart rate
— Goldman-Cecil Medicine, Table 56-6
Consider Revascularization If:
- Symptoms persist at CCS Class III/IV despite optimal medical therapy
- High-risk anatomy on imaging (LAD proximal lesion, left main disease, 3-vessel disease with LV dysfunction)
- Objective evidence of large ischemic territory
- In-stent restenosis confirmed on angiography
General Measures
- Smoking cessation (if smoker)
- Glycemic control (if diabetic)
- BP control (target < 130/80 mmHg)
- Cardiac rehabilitation / supervised exercise
- Dietary modification + weight management
Summary Algorithm
Known CAD + Post-PCI + Exertional Chest Pain
↓
Troponin −ve, ECG = Old septal Q waves (no new changes)
↓
→ Not ACS — Stable Ischemic Heart Disease
↓
Optimize DAPT / medical therapy (ASA + β-blocker + statin + ACEI)
↓
Functional testing (Stress Echo / Nuclear scan preferred over TMT)
↓
High-risk? → Coronary angiography → Consider revascularization
Low-risk? → Intensify medical therapy + risk factor control
Sources: Goldman-Cecil Medicine (Table 56-7, 56-6); Katzung's Basic & Clinical Pharmacology, 16th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.